Last updated on July 2019

Observational Study to Evaluate Allogeneic HSCT Outcomes for Cerebral Adrenoleukodystrophy (CALD)


Brief description of study

Study ALD-103 is a multi-site, global, data collection study designed to evaluate safety and efficacy of allogenic hematopoietic stem cell transplantation (allo-HSCT) in patients with CALD aged 17 or younger.

Clinical Study Identifier: NCT02204904

Find a site near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.